Stay updated with breaking news from Estates Consortium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Goulston & Storrs, an Am Law 200 firm, is pleased to announce that Kelly Aylward has joined its Boston office as a director in the firm's...
A new clinical trial study aims to learn why some adults infected with SARS-CoV-2 virus develop long COVID and why others don't.
The University of Kentucky is participating in a nationwide study that seeks to understand why some people have prolonged symptoms (long COVID) or develop new or returning symptoms after an acute bout of SARS-CoV-2 infection. Dr. Greg Davis talks with Zach Porterfield, M.D., Ph.D.,assistant professor in the UK Department of Microbiology, Immunology and Molecular Genetics, who is co-leading the study.
The University of Kentucky is participating in a nationwide study that seeks to understand why some people have prolonged symptoms (long COVID) or
The University of Kentucky is participating in a nationwide study that seeks to understand why some people have prolonged symptoms (long COVID) or develop new or returning symptoms after an acute bout of SARS-CoV-2 infection.